Literature DB >> 34270396

Disparities in receipt of medications for opioid use disorder among pregnant women.

Laura E Henkhaus1,2,3, Melinda B Buntin2,3, Sarah Clark Henderson2, Pikki Lai2, Stephen W Patrick2,3,4,5.   

Abstract

Background: Medications for opioid use disorder (MOUD) improve outcomes for pregnant women and infants. Our primary aim was to examine disparities in maternal MOUD receipt by family sociodemographic characteristics.
Methods: This retrospective cohort study included mother-infant dyads with Medicaid-covered deliveries in Tennessee from 2009 to 2016. First, we examined family sociodemographic characteristics - including race/ethnicity, rurality, mother's primary language and education level, and whether paternity was recorded in birth records - and newborn outcomes by type of maternal opioid use. Second, among pregnant women with OUD, we used logistic regression to measure disparities in receipt of MOUD by family sociodemographic characteristics including interactions between characteristics.
Results: Our cohort from Medicaid-covered deliveries consisted of 314,965 mother-infant dyads, and 4.2 percent were exposed to opioids through maternal use. Among dyads with maternal OUD, MOUD receipt was associated with lower rates of preterm and very preterm birth. Logistic regression adjusted for family sociodemographic characteristics showed that pregnant women with OUD in rural versus urban areas (aOR: 0.66; 95% CI: 0.60-0.72) and who were aged ≥35 years versus ≤25 years (aOR: 0.75; 95% CI: 0.64-0.89) were less likely to have received MOUD. Families in which the mother's primary language was English (aOR: 2.47; 95% CI: 1.24-4.91) and paternity was recorded on the birth certificate (aOR: 1.30; 95% CI: 1.19-1.42) were more likely to have received MOUD. Regardless of high school degree attainment, non-Hispanic Black versus non-Hispanic White race was associated with lower likelihood of MOUD receipt. Hispanic race was associated with lower likelihood of MOUD receipt among women without a high school degree. Conclusions: Among a large cohort of pregnant women, we found disparities in receipt of MOUD among non-Hispanic Black, Hispanic, and rural pregnant women. As policymakers consider strategies to improve access to MOUD, they should consider targeted approaches to address these disparities.

Entities:  

Keywords:  Opioid-related disorders; neonatology; obstetrics; social determinants of health

Mesh:

Substances:

Year:  2021        PMID: 34270396      PMCID: PMC8875287          DOI: 10.1080/08897077.2021.1949664

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  23 in total

1.  Nurse Practitioner and Physician Assistant Waivers to Prescribe Buprenorphine and State Scope of Practice Restrictions.

Authors:  Joanne Spetz; Christopher Toretsky; Susan Chapman; Bethany Phoenix; Matthew Tierney
Journal:  JAMA       Date:  2019-04-09       Impact factor: 56.272

2.  The associations of clinicians' implicit attitudes about race with medical visit communication and patient ratings of interpersonal care.

Authors:  Lisa A Cooper; Debra L Roter; Kathryn A Carson; Mary Catherine Beach; Janice A Sabin; Anthony G Greenwald; Thomas S Inui
Journal:  Am J Public Health       Date:  2012-03-15       Impact factor: 9.308

3.  Rural and Urban Differences in Neonatal Abstinence Syndrome and Maternal Opioid Use, 2004 to 2013.

Authors:  Nicole L G Villapiano; Tyler N A Winkelman; Katy B Kozhimannil; Matthew M Davis; Stephen W Patrick
Journal:  JAMA Pediatr       Date:  2017-02-01       Impact factor: 16.193

4.  Methodological issues in evaluating expanded Medicaid coverage for pregnant women.

Authors:  J M Piper; W A Ray; M R Griffin; R Fought; J R Daughtery; E Mitchel
Journal:  Am J Epidemiol       Date:  1990-09       Impact factor: 4.897

5.  Increased Severity of Neonatal Abstinence Syndrome Associated With Concomitant Antenatal Opioid and Benzodiazepine Exposure.

Authors:  Lauren A Sanlorenzo; William O Cooper; Judith A Dudley; Shannon Stratton; Faouzi I Maalouf; Stephen W Patrick
Journal:  Hosp Pediatr       Date:  2019-07-01

6.  Neonatal Outcomes in a Medicaid Population With Opioid Dependence.

Authors:  Susan B Brogly; Sonia Hernández-Diaz; Emily Regan; Ela Fadli; Kristen A Hahn; Martha M Werler
Journal:  Am J Epidemiol       Date:  2018-06-01       Impact factor: 4.897

Review 7.  Neonatal Opioid Withdrawal Syndrome.

Authors:  Stephen W Patrick; Wanda D Barfield; Brenda B Poindexter
Journal:  Pediatrics       Date:  2020-11       Impact factor: 7.124

8.  Comparison of Driving Times to Opioid Treatment Programs and Pharmacies in the US.

Authors:  Robert A Kleinman
Journal:  JAMA Psychiatry       Date:  2020-11-01       Impact factor: 21.596

9.  Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states.

Authors:  Stephen W Patrick; Melinda B Buntin; Peter R Martin; Theresa A Scott; William Dupont; Michael Richards; William O Cooper
Journal:  Subst Abus       Date:  2018-10-09       Impact factor: 3.984

Review 10.  Racism and health service utilisation: A systematic review and meta-analysis.

Authors:  Jehonathan Ben; Donna Cormack; Ricci Harris; Yin Paradies
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

View more
  1 in total

1.  Association of Individual and Community Factors With Hepatitis C Infections Among Pregnant People and Newborns.

Authors:  Stephen W Patrick; William D Dupont; Elizabeth McNeer; Melissa McPheeters; William O Cooper; David M Aronoff; Sarah Osmundson; Bradley D Stein
Journal:  JAMA Health Forum       Date:  2021-10-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.